7616.T - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 50/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

6/7 High

6 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.1x).

Beta (Market Relation)

0.07x

Defensive

Volatility (5Y p.a.)

23.3% p.a.

5-Year Horizon

Max Drawdown (5Y)

-38.9%

5-Year Horizon

Sharpe Ratio

0.04

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+18.5%
3 Years	23.4%	-33.4%	-0.27	-3.9%
5 Years	23.3%	-38.9%	0.04	+3.9%
10 Years	28.5%	-62.9%	-0.07	+0.6%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 232%.

🔴 High valuation risk: Avg P/E of 106.5 (Elevated multiple compression risk)

Strong cyclicality: The business model is sensitive to economic downturns.

Historical Stress Test: Maximum peak-to-trough drawdown of -62.9% in the extended horizon.